tyramine has been researched along with Dermatitis Medicamentosa in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this analysis is to present the safety profile of selegiline transdermal system (STS) in clinical practice after US Food and Drug Administration approval by analyzing reported postmarketing adverse events (AEs)." | 1.38 | Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. ( Bodkin, JA; Pae, CU; Patkar, AA; Portland, KB; Thase, ME, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, P | 1 |
| Kowalczyk, MC | 1 |
| Junco, JJ | 1 |
| Tolstykh, O | 1 |
| Kinjo, T | 1 |
| Truong, H | 1 |
| Walaszek, Z | 1 |
| Hanausek, M | 1 |
| Slaga, TJ | 1 |
| Pae, CU | 1 |
| Bodkin, JA | 1 |
| Portland, KB | 1 |
| Thase, ME | 1 |
| Patkar, AA | 1 |
2 other studies available for tyramine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
Topics: Acetates; Animals; Cyclooxygenase 2; Cytokines; Drug Eruptions; Epidermis; Female; Hyperplasia; Mice | 2013 |
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
Topics: Administration, Cutaneous; Adult; Adverse Drug Reaction Reporting Systems; Aged; Depressive Disorder | 2012 |